About SATIO INC
Satio is an emerging biotechnology firm transforming traditional blood collection, diagnostics, and drug delivery with simple, low-cost, and painless solutions. The company operates from Boston, MA, and partners with pharmaceutical companies, laboratories, and diagnostic firms.
Rapid and affordable detection, collection, and treatment solutionsAt-home drug and vaccine delivery using patch technologyDried Blood Spot and Whole Blood collection methodsIntradermal drug delivery systemsCollaboration with partners for LDT testing and diagnostic development
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| RESEARCH AND DEVELOPMENT - AOI #20 FOR THE DEVELOPMENT OF A LOW-COST, INTEGRATED, LATERAL FLOW IMMUNOASSAY AND | Department of Health and Human Services | $213K | |
| DEVELOPMENT OF DIGITAL SATIORX, A VERY LOW COST REMOTELY CONTROLLABLE DISPOSABLE MICRONEEDLE TRANSDERMAL DRUG | Department of Health and Human Services | $3.5M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SATIO INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.